TL;DR: zPREDICTA is a Y Combinator Summer 2015 startup Patient-derived 3D tissue reconstruction models for preclinical…, currently acquired with a team of 2.
Patient-derived 3D tissue reconstruction models for preclinical…
Last verified:
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug clas…
Built by LemStudio
Yes. zPREDICTA was funded by Y Combinator in the Summer 2015 batch. Patient-derived 3D tissue reconstruction models for preclinical…
zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the crit…
zPREDICTA was part of Y Combinator's Summer 2015 batch.
zPREDICTA has a team of 2 people according to Y Combinator's directory.
zPREDICTA is currently listed as Acquired with a team of 2 in Y Combinator's directory.
Loading interactive view…